May 15 |
Alimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...
|
May 14 |
Alimera Sciences, Inc. (ALIM) Q1 2024 Earnings Call Transcript
|
May 14 |
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
|
May 14 |
Alimera Sciences GAAP EPS of -$0.12 misses by $0.06, revenue of $23.01M beats by $0.76M
|
May 14 |
Alimera Sciences Reports First Quarter 2024 Results
|
May 13 |
Alimera Sciences Q1 2024 Earnings Preview
|
Apr 30 |
Alimera Sciences to Report First Quarter 2024 Financial ResultsĀ on May 14, 2024, and Provide Corporate Update
|
Mar 20 |
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 19 |
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
|
Mar 8 |
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript
|